{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T21:00:06Z","timestamp":1743109206155,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":54,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071617519"},{"type":"electronic","value":"9781071617526"}],"license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-1752-6_24","type":"book-chapter","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T21:02:28Z","timestamp":1636664548000},"page":"371-384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery"],"prefix":"10.1007","author":[{"given":"Danai Anastasia","family":"Panou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragna Guldsmed","family":"Diedrichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne M\u00f8rck","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"issue":"4","key":"24_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ (2020) Advances in oral peptide therapeutics. Nat Rev Drug Discov 19(4):277\u2013289","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"24_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","volume":"11","author":"B Homayun","year":"2019","unstructured":"Homayun B, Lin X, Choi HJ (2019) Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics 11(3):129","journal-title":"Pharmaceutics"},{"issue":"8","key":"24_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4155\/tde-2017-0024","volume":"8","author":"J Richard","year":"2017","unstructured":"Richard J (2017) Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects. Ther Deliv 8(8):663\u2013684","journal-title":"Ther Deliv"},{"issue":"6427","key":"24_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.aau2277","volume":"363","author":"A Abramson","year":"2019","unstructured":"Abramson A, Caffarel-Salvador E, Khang M et al (2019) An ingestible self-orienting system for oral delivery of macromolecules. Science 363(6427):611\u2013615","journal-title":"Science"},{"issue":"2","key":"24_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2016.1156805","volume":"4","author":"ST Buckley","year":"2016","unstructured":"Buckley ST, Hub\u00e1lek F, Rahbek UL (2016) Chemically modified peptides and proteins \u2013 critical considerations for oral delivery. Tissue Barriers 4(2):e1156805","journal-title":"Tissue Barriers"},{"issue":"2","key":"24_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics11020078","volume":"11","author":"C Twarog","year":"2019","unstructured":"Twarog C, Fattah S, Heade J, Maher S, Fattal E, Brayden DJ (2019) Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (c10). Pharmaceutics 11(2):1\u201321","journal-title":"Pharmaceutics"},{"issue":"15","key":"24_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.addr.2009.09.006","volume":"61","author":"S Maher","year":"2009","unstructured":"Maher S, Leonard TW, Jacobsen J, Brayden DJ (2009) Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. Adv Drug Deliv Rev 61(15):1427\u20131449","journal-title":"Adv Drug Deliv Rev"},{"key":"24_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2017.09.025","volume":"268","author":"S Harloff-Helleberg","year":"2017","unstructured":"Harloff-Helleberg S, Nielsen LH, Nielsen HM (2017) Animal models for evaluation of oral delivery of biopharmaceuticals. J Control Release 268:57\u201371","journal-title":"J Control Release"},{"key":"24_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.peptides.2017.12.014","volume":"100","author":"S Rehmani","year":"2018","unstructured":"Rehmani S, Dixon JE (2018) Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies. Peptides 100:24\u201335","journal-title":"Peptides"},{"issue":"1","key":"24_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-30790-2","volume":"8","author":"K Hoffmann","year":"2018","unstructured":"Hoffmann K, Milech N, Juraja SM et al (2018) A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular delivery. Sci Rep 8(1):1\u201316","journal-title":"Sci Rep"},{"issue":"3","key":"24_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbamem.2006.01.006","volume":"1758","author":"S Pujals","year":"2006","unstructured":"Pujals S, Fern\u00e1ndez-Carneado J, L\u00f3pez-Iglesias C, Kogan MJ, Giralt E (2006) Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. Biochim Biophys Acta Biomembr 1758(3):264\u2013279","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"Pt B","key":"24_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.addr.2016.04.031","volume":"106","author":"M S\u00e1nchez-Navarro","year":"2016","unstructured":"S\u00e1nchez-Navarro M, Garcia J, Giralt E, Teixid\u00f3 M (2016) Using peptides to increase transport across the intestinal barrier. Adv Drug Deliv Rev 106(Pt B):355\u2013366","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"24_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1021\/acs.bioconjchem.7b00687","volume":"29","author":"M Kristensen","year":"2018","unstructured":"Kristensen M, Nielsen LH, Zor K et al (2018) Cellular effects and delivery propensity of penetratin is influenced by conjugation to parathyroid hormone fragment 1-34 in synergy with pH. Bioconjug Chem 29(2):371\u2013381","journal-title":"Bioconjug Chem"},{"issue":"2","key":"24_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21688370.2016.1178369","volume":"4","author":"M Kristensen","year":"2016","unstructured":"Kristensen M, Nielsen HM (2016) Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals. Tissue Barriers 4(2):1\u201315","journal-title":"Tissue Barriers"},{"issue":"2","key":"24_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3390\/ijms17020185","volume":"17","author":"M Kristensen","year":"2016","unstructured":"Kristensen M, Birch D, Nielsen HM (2016) Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. Int J Mol Sci 17(2):185","journal-title":"Int J Mol Sci"},{"issue":"5","key":"24_CR16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1208\/s12248-015-9747-3","volume":"17","author":"M Kristensen","year":"2015","unstructured":"Kristensen M, Franzyk H, Klausen MT et al (2015) Penetratin-mediated transepithelial insulin permeation: importance of cationic residues and pH for complexation and permeation. AAPS J 17(5):1200\u20131209","journal-title":"AAPS J"},{"issue":"3","key":"24_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/bc5005763","volume":"26","author":"M Kristensen","year":"2015","unstructured":"Kristensen M, De Groot AM, Berthelsen J, Franzyk H, Sijts A, Nielsen HM (2015) Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation. Bioconjug Chem 26(3):477\u2013488","journal-title":"Bioconjug Chem"},{"key":"24_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2014.08.014","volume":"194","author":"NQ Shi","year":"2014","unstructured":"Shi NQ, Qi XR, Xiang B, Zhang Y (2014) A survey on \u201ctrojan horse\u201d peptides: Opportunities, issues and controlled entry to \u201ctroy\u201d. J Control Release 194:53\u201370","journal-title":"J Control Release"},{"issue":"5","key":"24_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24050927","volume":"24","author":"J Habault","year":"2019","unstructured":"Habault J, Poyet JL (2019) Recent advances in cell penetrating peptide-based anticancer therapies. Molecules 24(5):1\u201317","journal-title":"Molecules"},{"issue":"11","key":"24_CR20","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1002\/jps.23708","volume":"102","author":"N Kamei","year":"2013","unstructured":"Kamei N, Onuki Y, Takayama K, Takeda-Morishita M (2013) Mechanistic study of the uptake\/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport. J Pharm Sci 102(11):3998\u20134008","journal-title":"J Pharm Sci"},{"issue":"3","key":"24_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.bbrc.2005.07.142","volume":"335","author":"JF Liang","year":"2005","unstructured":"Liang JF, Yang VC (2005) Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency. Biochem Biophys Res Commun 335(3):734\u2013738","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"24_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jconrel.2006.12.022","volume":"118","author":"M Morishita","year":"2007","unstructured":"Morishita M, Kamei N, Ehara J, Isowa K, Takayama K (2007) A novel approach using functional peptides for efficient intestinal absorption of insulin. J Control Release 118(2):177\u2013184","journal-title":"J Control Release"},{"issue":"1","key":"24_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jconrel.2008.08.001","volume":"132","author":"N Kamei","year":"2008","unstructured":"Kamei N, Morishita M, Eda Y, Ida N, Nishio R, Takayama K (2008) Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. J Control Release 132(1):21\u201325","journal-title":"J Control Release"},{"issue":"2","key":"24_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/jps.23364","volume":"102","author":"N Kamei","year":"2013","unstructured":"Kamei N, Kikuchi S, Takeda-Morishita M et al (2013) Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps. J Pharm Sci 102(2):469\u2013479","journal-title":"J Pharm Sci"},{"key":"24_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jconrel.2018.09.003","volume":"288","author":"K Almansour","year":"2018","unstructured":"Almansour K, Taverner A, Turner JR, Eggleston IM, Mrsny RJ (2018) An intestinal paracellular pathway biased toward positively-charged macromolecules. J Control Release 288:111\u2013125","journal-title":"J Control Release"},{"key":"24_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2015.05.270","volume":"210","author":"A Taverner","year":"2015","unstructured":"Taverner A, Dondi R, Almansour K et al (2015) Enhanced paracellular transport of insulin can be achieved via transient induction of myosin light chain phosphorylation. J Control Release 210:189\u2013197","journal-title":"J Control Release"},{"key":"24_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2018.03.033","volume":"279","author":"K Almansour","year":"2018","unstructured":"Almansour K, Taverner A, Eggleston IM, Mrsny RJ (2018) Mechanistic studies of a cell-permeant peptide designed to enhance myosin light chain phosphorylation in polarized intestinal epithelia. J Control Release 279:208\u2013219","journal-title":"J Control Release"},{"key":"24_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","volume":"189","author":"EJB Nielsen","year":"2014","unstructured":"Nielsen EJB, Yoshida S, Kamei N et al (2014) In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin. J Control Release 189:19\u201324","journal-title":"J Control Release"},{"issue":"10","key":"24_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12100993","volume":"12","author":"M Kristensen","year":"2020","unstructured":"Kristensen M, Diedrichsen RG, Vetri V, Foder\u00e0 V, Nielsen HM (2020) Increased carrier peptide stability through pH adjustment improves insulin and PTH(1-34) delivery in vitro and in vivo rather than by enforced carrier peptide-cargo complexation. Pharmaceutics 12(10):1\u201318","journal-title":"Pharmaceutics"},{"key":"24_CR30","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jcis.2020.05.121","volume":"578","author":"SF Hedegaard","year":"2020","unstructured":"Hedegaard SF, Bruhn DS, Khandelia H, C\u00e1rdenas M, Nielsen HM (2020) Shuffled lipidation pattern and degree of lipidation determines the membrane interaction behavior of a linear cationic membrane-active peptide. J Colloid Interface Sci 578:584\u2013597","journal-title":"J Colloid Interface Sci"},{"issue":"10","key":"24_CR31","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1042\/BCJ20180155","volume":"475","author":"D Birch","year":"2018","unstructured":"Birch D, Christensen MV, Staerk D, Franzyk H, Nielsen HM (2018) Stereochemistry as a determining factor for the effect of a cell-penetrating peptide on cellular viability and epithelial integrity. Biochem J 475(10):1773\u20131788","journal-title":"Biochem J"},{"issue":"1","key":"24_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/bj20030760","volume":"377","author":"ME Lindgren","year":"2004","unstructured":"Lindgren ME, H\u00e4llbrink MM, Elmquist AM, Langel \u00dc (2004) Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem J 377(1):69\u201376","journal-title":"Biochem J"},{"issue":"6","key":"24_CR33","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1208\/s12248-015-9804-y","volume":"17","author":"ES Khafagy","year":"2015","unstructured":"Khafagy ES, Iwamae R, Kamei N, Takeda-Morishita M (2015) Region-dependent role of cell-penetrating peptides in insulin absorption across the rat small intestinal membrane. AAPS J 17(6):1427\u20131437","journal-title":"AAPS J"},{"issue":"6","key":"24_CR34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1021\/js970372e","volume":"87","author":"P Anderle","year":"1998","unstructured":"Anderle P, Niederer E, Rubas W et al (1998) P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J Pharm Sci 87(6):757\u2013762","journal-title":"J Pharm Sci"},{"issue":"2","key":"24_CR35","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","volume":"96","author":"IJ Hidalgo","year":"1989","unstructured":"Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96(2):736\u2013749","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"24_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.addr.2012.09.005","volume":"64","author":"P Artursson","year":"2012","unstructured":"Artursson P, Palm K, Luthman K (2012) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 64(Suppl):280\u2013289","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"24_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.xphs.2015.10.030","volume":"105","author":"M \u00d6lander","year":"2016","unstructured":"\u00d6lander M, Wi\u015bniewski JR, Matsson P, Lundquist P, Artursson P (2016) The proteome of filter-grown Caco-2 cells with a focus on proteins involved in drug disposition. J Pharm Sci 105(2):817\u2013827","journal-title":"J Pharm Sci"},{"key":"24_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","volume":"57","author":"E Sj\u00f6gren","year":"2014","unstructured":"Sj\u00f6gren E, Abrahamsson B, Augustijns P et al (2014) In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects. Eur J Pharm Sci 57:99\u2013151","journal-title":"Eur J Pharm Sci"},{"issue":"3\u20134","key":"24_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00756522","volume":"11","author":"V Meunier","year":"1995","unstructured":"Meunier V, Bourri\u00e9 M, Berger Y, Fabre G (1995) The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biol Toxicol 11(3\u20134):187\u2013194","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"24_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1021\/bp050208u","volume":"22","author":"P Shah","year":"2006","unstructured":"Shah P, Jogani V, Bagchi T, Misra A (2006) Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol Prog 22(1):186\u2013198","journal-title":"Biotechnol Prog"},{"issue":"1","key":"24_CR41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-physiol-012110-142150","volume":"73","author":"L Shen","year":"2011","unstructured":"Shen L, Weber CR, Raleigh DR, Yu D, Turner JR (2011) Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol 73(1):283\u2013309","journal-title":"Annu Rev Physiol"},{"issue":"11","key":"24_CR42","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.bbamem.2010.07.014","volume":"1798","author":"S Milatz","year":"2010","unstructured":"Milatz S, Krug SM, Rosenthal R et al (2010) Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta Biomembr 1798(11):2048\u20132057","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1","key":"24_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/nyas.13374","volume":"1397","author":"CR Weber","year":"2017","unstructured":"Weber CR, Turner JR (2017) Dynamic modeling of the tight junction pore pathway. Ann N Y Acad Sci 1397(1):209\u2013218","journal-title":"Ann N Y Acad Sci"},{"key":"24_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2016.00087","volume":"6","author":"P Ugalde-Silva","year":"2016","unstructured":"Ugalde-Silva P, Gonzalez-Lugo O, Navarro-Garcia F (2016) Tight junction disruption induced by type 3 secretion system effectors injected by enteropathogenic and enterohemorrhagic Escherichia coli. Front Cell Infect Microbiol 6:1\u201312","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"24_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-15108-y","volume":"7","author":"A Watari","year":"2017","unstructured":"Watari A, Kodaka M, Matsuhisa K et al (2017) Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay. Sci Rep 7(1):1\u201312","journal-title":"Sci Rep"},{"issue":"1","key":"24_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","volume":"81","author":"L Gonz\u00e1lez-Mariscal","year":"2003","unstructured":"Gonz\u00e1lez-Mariscal L, Betanzos A, Nava P, Jaramillo BE (2003) Tight junction proteins. Prog Biophys Mol Biol 81(1):1\u201344","journal-title":"Prog Biophys Mol Biol"},{"key":"24_CR47","doi-asserted-by":"crossref","unstructured":"Bocsik A, Gr\u00f3f I, Kiss L et al (2019) Dual action of the PN159\/KLAL\/MAP peptide: increase of drug penetration across Caco-2 intestinal barrier model by modulation of tight junctions and plasma membrane permeability. Pharmaceutics 11(2)","DOI":"10.3390\/pharmaceutics11020073"},{"issue":"4","key":"24_CR48","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","volume":"1788","author":"MA Deli","year":"2009","unstructured":"Deli MA (2009) Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta Biomembr 1788(4):892\u2013910","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"3","key":"24_CR49","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.bbamem.2007.08.018","volume":"1778","author":"L Gonz\u00e1lez-Mariscal","year":"2008","unstructured":"Gonz\u00e1lez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta Biomembr 1778(3):729\u2013756","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"1","key":"24_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1083\/jcb.138.1.181","volume":"138","author":"M Itoh","year":"1997","unstructured":"Itoh M, Nagafuchi A, Moroi S, Tsukita S (1997) Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to \u03b1 catenin and actin filaments. J Cell Biol 138(1):181\u2013192","journal-title":"J Cell Biol"},{"key":"24_CR51","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2020.04.023","volume":"152","author":"C Twarog","year":"2020","unstructured":"Twarog C, Liu K, O\u2019Brien PJ et al (2020) A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10). Eur J Pharm Biopharm 152:95\u2013107","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"24_CR52","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.xphs.2015.11.018","volume":"105","author":"A Bocsik","year":"2016","unstructured":"Bocsik A, Walter FR, Gyebrovszki A et al (2016) Reversible opening of intercellular junctions of intestinal epithelial and brain endothelial cells with tight junction modulator peptides. J Pharm Sci 105(2):754\u2013765","journal-title":"J Pharm Sci"},{"key":"24_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-1-4939-2806-4_17","volume-title":"Cell-penetrating peptides: methods and protocols","author":"S R\u00f8nholt","year":"2015","unstructured":"R\u00f8nholt S, Kristensen M, Nielsen HM (2015) Cell-penetrating peptides as carriers for transepithelial drug delivery in vitro. In: Langel \u00dc (ed) Cell-penetrating peptides: methods and protocols, 2nd edn. Springer, New York, pp 261\u2013277","edition":"2"},{"issue":"11","key":"24_CR54","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1002\/pro.5560041120","volume":"4","author":"CN Pace","year":"1995","unstructured":"Pace CN, Vajdos F, Fee L, Grimsley G, Gray T (1995) How to measure and predict the molar absorption coefficient of a protein. Protein Sci 4(11):2411\u20132423","journal-title":"Protein Sci"}],"container-title":["Methods in Molecular Biology","Cell Penetrating Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-1752-6_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T11:09:16Z","timestamp":1666350556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-1752-6_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"ISBN":["9781071617519","9781071617526"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-1752-6_24","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2021,11,12]]},"assertion":[{"value":"12 November 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}